Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tejal A Patel
Dual HER2 Blockade: Preclinical and Clinical Data
Breast Cancer Research
Cancer Research
Oncology
Related publications
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity Against Breast Cancer Models Resistant to Anti-Her2 Drugs
PLoS ONE
Multidisciplinary
Neue Wege Bei Der HER2-Blockade
InFo Onkologie
The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Preclinical and Clinical Data for Factor Xa and “Universal” Reversal Agents
American Journal of Medicine
Medicine
Dual HER2 Blockade Versus a Single Agent in Trastuzumab-Containing Regimens for HER2-Positive Early Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Journal of Oncology
Oncology
Sequential HER2 Blockade as Effective Therapy in Chemorefractory, HER2 Gene-Amplified, RAS Wild-Type, Metastatic Colorectal Cancer: Learning From a Clinical Case
ESMO Open
Cancer Research
Oncology
Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): From Preclinical Experiments Towards Possible Clinical Anticancer Applications
Journal of Cancer
Oncology
Dual PI3K/mTORC1 Targeting Suppresses HER2+ Brain Metastasis Xenografts
Cancer Discovery
Oncology
Predictability in Psychopharmacology: Preclinical and Clinical Correlations
BMJ
